Cubist Systematic Strategies’s Burning Rock Biotech BNR Stock Holding History

Cubist Systematic Strategies’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,805	Closed	-$67K	–	4256
2022 Q3	$67K	Sell	2,805 -4,374	-61%	-$141K	﹤0.01%	4088
2022 Q2	$209K	Buy	+7,179	New	+$321K	﹤0.01%	3666
2022 Q1	–	Sell	-8,263	Closed	-$787K	–	3564
2021 Q4	$787K	Buy	+8,263	New	+$1.13M	0.01%	2109
2021 Q3	–	Sell	-1,078	Closed	-$317K	–	2966
2021 Q2	$317K	Buy	+1,078	New	+$319K	﹤0.01%	2289
2020 Q3	–	Sell	-41	Closed	-$11K	–	2490
2020 Q2	$11K	Buy	+41	New	+$11.2K	﹤0.01%	2339

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cubist Systematic Strategies's BNR Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of Burning Rock Biotech (BNR) in Q4 2022, closing a stake of 2,805 shares — an estimated $67K sold.

Cubist Systematic Strategies first reported a position in BNR in Q2 2020 and held it in 5 quarters. The position peaked at $787K in Q4 2021. 42 funds tracked by Wall St. Rank hold BNR as of Q4 2022.

Cubist Systematic Strategies reported no remaining Burning Rock Biotech position as of Q4 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 2,805 Burning Rock Biotech shares in Q4 2022, an estimated $67K.
Cubist Systematic Strategies first reported a position in Burning Rock Biotech in Q2 2020 and held it in 5 quarters.
Cubist Systematic Strategies's Burning Rock Biotech position peaked at $787K in Q4 2021.
42 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.